Aveanna Healthcare (NASDAQ:AVAH) Trading Up 6.8% Following Analyst Upgrade

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s stock price traded up 6.8% during mid-day trading on Monday after UBS Group raised their price target on the stock from $3.20 to $4.50. UBS Group currently has a sell rating on the stock. Aveanna Healthcare traded as high as $5.56 and last traded at $5.55. 280,641 shares were traded during trading, an increase of 21% from the average session volume of 232,508 shares. The stock had previously closed at $5.19.

Separately, Truist Financial dropped their price target on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a report on Monday, January 6th.

Institutional Investors Weigh In On Aveanna Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the company. Mackenzie Financial Corp boosted its stake in shares of Aveanna Healthcare by 254.2% during the 4th quarter. Mackenzie Financial Corp now owns 107,223 shares of the company’s stock worth $490,000 after buying an additional 76,953 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new stake in Aveanna Healthcare in the 4th quarter valued at about $121,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Aveanna Healthcare during the fourth quarter worth approximately $223,000. Squarepoint Ops LLC raised its stake in Aveanna Healthcare by 586.1% in the fourth quarter. Squarepoint Ops LLC now owns 75,538 shares of the company’s stock valued at $345,000 after buying an additional 64,528 shares during the period. Finally, State of Wyoming bought a new position in shares of Aveanna Healthcare during the 4th quarter worth approximately $179,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Stock Performance

The business has a fifty day moving average of $4.56 and a two-hundred day moving average of $4.96. The firm has a market capitalization of $1.08 billion, a price-to-earnings ratio of -16.43 and a beta of 2.25.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.